Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

347.86
Delayed Data
As of Jun 29
 +8.08 / +2.38%
Today’s Change
329.09
Today|||52-Week Range
605.93
-35.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line194.6M210.4M155.0M165.7M
 
 
 
 
 
Depreciation15.3M20.7M22.9M23.0M
 
 
 
 
 
Total Other Cash Flow122.2M115.5M160.8M146.2M
 
 
 
 
 
Funds From Operations284.0M339.7M283.1M255.1M
 
 
 
 
 
Funds From/For Other Operating Expenses40.4M-553.2M1.3M225.8M
 
 
 
 
 
Net Cash Flow - Operating Activities243.6M892.9M281.8M29.3M
 
 
 
 
 
 
InvestingIncrease In Investments-245.1M-209.3M-7.0M0.00
 
 
 
 
Decrease In Investments113.3M72.2M61.4M60.4M
 
 
 
 
 
Capital Expenditures-239.9M-146.1M-177.8M-104.1M
 
 
 
 
 
Net Cash Flow Investing-371.6M-283.2M-123.3M-43.7M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings26.8M-375.0K-385.0K0.00
 
 
 
 
Long Term Debt Reduction-134.1M-2.0M-20.5M-2.3M
 
 
 
 
 
Net Proceeds Stock Sale39.6M34.6M55.9M39.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing93.1M56.8M99.8M15.6M
 
 
 
 
 
Other Uses - Financing14.7M434.7M138.9M243.2M
 
 
 
 
 
Net Cash Flow - Financing10.7M-345.6M-4.0M-190.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-117.4M264.0M154.5M-204.9M